title: Is the use of topical antibiotics for intravitreal injections the standard of care or are we better off without antibiotics?
authors.forename: Royce W S
authors.initials: RW
authors.lastname: Chen
authors.forename: Aleksandra
authors.initials: A
authors.lastname: Rachitskaya
authors.forename: Ingrid U
authors.initials: IU
authors.lastname: Scott
authors.forename: Harry W
authors.initials: HW
authors.lastname: Flynn
mesh_terms: D000287:Administration, Topical; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D009877:Endophthalmitis / Q000517:prevention & control*; D006801:Humans; D058449:Intravitreal Injections; D009883:Ophthalmic Solutions; D011206:Povidone-Iodine / Q000627:therapeutic use; D059039:Standard of Care; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014822:Vitreous Body / Q000187:drug effects
chemical_list: D020533:Angiogenesis Inhibitors; D000900:Anti-Bacterial Agents; D009883:Ophthalmic Solutions; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D011206:Povidone-Iodine